Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice
(Q28260292)
scientific article
scientific article
Language:
Current Data About
Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice
(P31) |
(Q13442814)
|
||||||||||||||||
(P50) |
(Q54106987)
(Q41781636)
(Q54107020)
(Q56423923)
|
||||||||||||||||
(P304) |
100-7
|
||||||||||||||||
(P407) |
(Q1860)
|
||||||||||||||||
(P433) |
1
|
||||||||||||||||
(P478) |
81
|
||||||||||||||||
(P577) |
+2007-01-00T00:00:00Z
|
||||||||||||||||
(P921) |
(Q929737)
|
||||||||||||||||
(P1433) |
(Q1524048)
|
||||||||||||||||
(P1476) |
"Treatment with HMGB1 inhibitors diminishes CTL-induced liver disease in HBV transgenic mice" (language: en)
|
||||||||||||||||
(P2093) |
Marco E Bianchi
|